OraSure Technologies, Inc. revenue for the last year amounted to 185.83 M USD, the most of which — 60.80 M USD — came from its highest performing source at the moment, Human Immunodeficiency Virus, the year earlier bringing 60.82 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought OraSure Technologies, Inc. 139.16 M USD, and the year before that — 361.66 M USD.